Autophagy in the liver: Functions in health and disease

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 3, 2017, Pages 170-184

  Ueno, Takashi ^a   Komatsu, Masaaki ^b  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FATTY ACID; GLUCAGON; GLUCOSE; HORMONE; PARKIN; SEQUESTOSOME 1; TRANSCRIPTION FACTOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOPHAGY; CELL ORGANELLE; CONCENTRATION (PARAMETERS); ENERGY METABOLISM; FATTY ACID OXIDATION; GENE IDENTIFICATION; GLUCONEOGENESIS; GLYCOGENOLYSIS; GLYCOPHAGY; HEALTH; HUMAN; LIPID OXIDATION; LIPOPHAGOCYTOSIS; LIVER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER METABOLISM; LYSOSOME; METABOLIC STRESS; MITOCHONDRION; MITOPHAGY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PEXOPHAGY; PHYSIOLOGY; REGULATORY MECHANISM; REVIEW; VIRUS HEPATITIS; LIPID PEROXIDATION; LIVER DISEASES; METABOLISM; PATHOPHYSIOLOGY;

AMINO ACIDS; AUTOPHAGY; GLUCONEOGENESIS; HUMANS; LIPID PEROXIDATION; LIVER; LIVER DISEASES;

EID: 85008330539     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2016.185     Document Type: Review

References (224)

1. Appelmans, F., Wattiaux, R. & De Duve, C. Tissue fractionation studies. 5. The association of acid phosphatase with a special class of cytoplasmic granules in rat liver. Biochem. J. 59, 438-445 (1955).
2. De Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R. & Appelmans, F. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem. J. 60, 604-617 (1955).
3. Beaufay, H., Bendall, D. S., Baudhun, P., Wattiaux, R. & De Duve, C. Tissue fractionation studies. 13. Analysis of mitochondrial fractions from rat liver by density-gradient centrifuging. Biochem. J. 73, 628-637 (1959).
4. Novikoff, A. B., Beaufay, H. & De Duve, C. Electron microscopy of lysosomerich fractions from rat liver. J. Biophys. Biochem. Cytol. 2, 179-184 (1956).
5. Essner, E. & Novikoff, A. B. Localization of acid phosphatase activity in hepatic lysosomes by means of electron microscopy. J. Biophys. Biochem. Cytol. 9, 773-784 (1961).
6. Straus, W. Rapid cytochemical identification of phagosomes in various tissues of the rat and their differentiation from mitochondria by the peroxidase method. J. Biophys. Biochem. Cytol. 5, 193-204 (1959).
7. Straus, W. Cytochemical observations on the relationship between lysosomes and phagosomes in kidney and liver by combined staining for acid phosphatase and intravenously injected horseradish peroxidase. J. Cell Biol. 20, 497-507 (1964).
8. Clark, S. L. Jr. Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J. Biophys. Biochem. Cytol. 3, 349-362 (1957).
9. Novikoff, A. B. The proximal tubule cell in experimental hydronephrosis. J. Biophys. Biochem. Cytol. 6, 136-138 (1959).
10. Ashford, T. P. & Porter, K. R. Cytoplasmic components in hepatic cell lysosomes. J. Cell Biol. 12, 198-202 (1962).
11. Novikoff, A. B. & Essner, E. Cytolysomes and mitochondrial degeneration. J. Cell Biol. 15, 140-146 (1962).
12. Moe, H. & Behnke, O. Cytoplasmic bodies containing mitochondria, ribosomes, and rough surfaced endoplasmic membranes in the epithelium of the small intestine of newborn rats. J. Cell Biol. 13, 168-171 (1962).
13. Hruban, Z., Spargo, B., Swift, H., Wissler, R. W. & Kleinfeld, R. G. Focal cytoplasmic degradation. Am. J. Pathol. 42, 657-683 (1963).
14. Miller, L. L. Glucagon: A protein catabolic hormone in the isolated perfused rat liver. Nature 185, 248 (1960).
15. De Duve, C. The lysosome. Sci. Am. 208, 64-72 (1963).
16. De Duve, C. & Wattiaux, R. Functions of lysosomes. Annu. Rev. Physiol. 28, 435-492 (1966).
17. Mizushima, N., Levine, B., Cuervo, A. M. & Klionsky, D. J. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075 (2008).
18. Arstila, A. U. & Trump, B. F. Studies on cellular autophagocytosis. The formation of autophagic vacuoles in the liver after glucagon administration. Am. J. Pathol. 53, 687-733 (1968).
19. Ericsson, J. L. Studies on induced cellular autophagy. II. Characterization of the membranes bordering autophagosomes in parenchymal liver cells. Exp. Cell Res. 56, 393-405 (1969).
20. Furuno, K. et al. Immunocytochemical study of the surrounding envelope of autophagic vacuoles in cultured rat hepatocytes. Exp. Cell Res. 189, 261-268 (1990).
21. Dunn, W. A. Jr. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J. Cell Biol. 110, 1923-1933 (1990).
22. Masaki, R., Yamamoto, A. & Tashiro, Y. Cytochrome P-450 and NADPH-cytochrome P-450 reductase are degraded in the autolysosomes in rat liver. J. Cell Biol. 104, 1207-1215 (1987).
23. Locke, M. & Sykes, A. K. The role of the Golgi complex in the isolation and digestion of organelles. Tissue Cell 7, 143-158 (1975).
24. Yamamoto, A., Masaki, R. & Tashiro, Y. Characterization of the isolation membranes and the limiting membranes of autophagosomes in rat hepatocytes by lectin cytochemistry. J. Histochem. Cytochem. 38, 573-580 (1990).
25. Seglen, P. O., Gordon, P. B. & Holen, I. Non-selective autophagy. Semin. Cell Biol. 1, 441-448 (1990).
26. Rez, G. & Meldolesi, J. Freeze-fracture of drug-induced autophagocytosis in the mouse exocrine pancreas. Lab. Invest. 43, 269-277 (1980).
27. Baba, M., Takeshige, K., Baba, N. & Ohsumi, Y. Ultrastructural analysis of the autophagic process in yeast: detection of autophagosomes and their characterization. J. Cell Biol. 124, 903-913 (1994).
28. Tsukada, M. & Ohsumi, Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 333, 169-174 (1993).
29. Thumm, M. et al. Isolation of autophagocytosis mutants of Saccharomyces cerevisiae. FEBS Lett. 349, 275-280 (1994).
30. Harding, T. M., Hefner-Gravink, A., Thumm, M. & Klionsky, D. J. Genetic and phenotypic overlap between autophagy and the cytoplasm to vacuole protein targeting pathway. J. Biol. Chem. 271, 17621-17624 (1996).
31. Klionsky, D. J. et al. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5, 539-545 (2003).
32. Ravikumar, B., Moreau, K., Jahreiss, L., Puri, C. & Rubinsztein, D. C. Plasma membrane contributes to the formation of pre-Autophagosomal structures. Nat. Cell Biol. 12, 747-757 (2010).
33. Yla-Anttila, P., Vihinen, H., Jokitalo, E. & Eskelinen, E. L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 5, 1180-1185 (2009).
34. Hayashi-Nishino, M. et al. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat. Cell Biol. 11, 1433-1437 (2009).
35. Hamasaki, M. et al. Autophagosomes form at ER-mitochondria contact sites. Nature 495, 389-393 (2013).
36. Yen, W. L. et al. The conserved oligomeric Golgi complex is involved in double-membrane vesicle formation during autophagy. J. Cell Biol. 188, 101-114 (2010).
37. Schneider, J. L. & Cuervo, A. M. Liver autophagy: much more than just taking out the trash. Nat. Rev. Gastroenterol. Hepatol. 11, 187-200 (2014).
38. Nakatogawa, H., Suzuki, K., Kamada, Y. & Ohsumi, Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 10, 458-467 (2009).
39. Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27, 107-132 (2011).
40. Meley, D. et al. AMP-Activated protein kinase and the regulation of autophagic proteolysis. J. Biol. Chem. 281, 34870-34879 (2006).
41. Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141 (2011).
42. Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963-3966 (1998).
43. Kamada, Y. et al. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507-1513 (2000).
44. Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981-1991 (2009).
45. Jung, C. H. et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992-2003 (2009).
46. Itakura, E., Kishi-Itakura, C. & Mizushima, N. The hairpin-Type tail-Anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151, 1256-1269 (2012).
47. Diao, J. et al. ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomes. Nature 520, 563-566 (2015).
48. McEwan, D. G. et al. PLEKHM1 regulates autophagosome-lysosome fusion through HOPS complex and LC3/GABARAP proteins. Mol. Cell 57, 39-54 (2015).
49. Khaminets, A., Behl, C. & Dikic, I. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 26, 6-16 (2016).
50. Rogov, V., Dotsch, V., Johansen, T. & Kirkin, V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol. Cell 53, 167-178 (2014).
51. Fujita, N. et al. Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J. Cell Biol. 203, 115-128 (2013).
52. Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309-314 (2015).
53. Koyano, F. et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162-166 (2014).
54. Kane, L. A. et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143-153 (2014).
55. Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370-375 (2014).
56. Heo, J. M., Ordureau, A., Paulo, J. A., Rinehart, J. & Harper, J. W. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7-20 (2015).
57. Richter, B. et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl Acad. Sci. USA 113, 4039-4044 (2016).
58. Tripathi, D. N. & Walker, C. L. The peroxisome as a cell signaling organelle. Curr. Opin. Cell Biol. 39, 109-112 (2016).
59. Till, A., Lakhani, R., Burnett, S. F. & Subramani, S. Pexophagy: The selective degradation of peroxisomes. Int. J. Cell Biol. 2012, 512721 (2012).
60. Kim, P. K., Hailey, D. W., Mullen, R. T. & Lippincott-Schwartz, J. Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc. Natl Acad. Sci. USA 105, 20567-20574 (2008).
61. Iwata, J. et al. Excess peroxisomes are degraded by autophagic machinery in mammals. J. Biol. Chem. 281, 4035-4041 (2006).
62. Watters, D. et al. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274, 34277-34282 (1999).
63. Zhang, J. et al. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat. Cell Biol. 17, 1259-1269 (2015).
64. Tripathi, D. N. et al. Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. Proc. Natl Acad. Sci. USA 110, E2950-E2957 (2013).
65. Walter, K. M. et al. Hif-2a promotes degradation of mammalian peroxisomes by selective autophagy. Cell Metab. 20, 882-897 (2014).
66. Deosaran, E. et al. NBR1 acts as an autophagy receptor for peroxisomes. J. Cell Sci. 126, 939-952 (2013).
67. Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
68. Martinez-Lopez, N. & Singh, R. Autophagy and lipid droplets in the liver. Annu. Rev. Nutr. 35, 215-237 (2015).
69. Kaushik, S. et al. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 14, 173-183 (2011).
70. Coupe, B. et al. Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregulation. Cell Metab. 15, 247-255 (2012).
71. Kaushik, S. & Cuervo, A. M. Degradation of lipid droplet-Associated proteins by chaperone-mediated autophagy facilitates lipolysis. Nat. Cell Biol. 17, 759-770 (2015).
72. Martinez-Lopez, N. et al. Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the brown adipose tissue and liver. Cell Metab. 23, 113-127 (2016).
73. Jiang, S. et al. Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. J. Biol. Chem. 285, 34960-34971 (2010).
74. Jiang, S., Wells, C. D. & Roach, P. J. Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem. Biophys. Res. Commun. 413, 420-425 (2011).
75. Zhu, Y., Zhang, M., Kelly, A. R. & Cheng, A. The carbohydrate-binding domain of overexpressed STBD1 is important for its stability and protein-protein interactions. Biosci. Rep. 34, e00117 (2014).
76. Sun, T., Yi, H., Yang, C., Kishnani, P. S. & Sun, B. Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver. J. Biol. Chem. 291, 16479-16484 (2016).
77. Komatsu, M. et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223 (2010).
78. Jain, A. et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576-22591 (2010).
79. Lau, A. et al. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30, 3275-3285 (2010).
80. Taguchi, K. et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc. Natl Acad. Sci. USA 109, 13561-13566 (2012).
81. Ichimura, Y. et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51, 618-631 (2013).
82. Bae, S. H. et al. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab. 17, 73-84 (2013).
83. Ro, S. H. et al. Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of p62/sequestosome-1. FEBS J. 281, 3816-3827 (2014).
84. Pfeifer, U. Inverted diurnal rhythm of cellular autophagy in liver cells of rats fed a single daily meal. Virchows Arch. B Cell Pathol. 10, 1-3 (1972).
85. Eng, C. H., Yu, K., Lucas, J., White, E. & Abraham, R. T. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal. 3, ra31 (2010).
86. Cheong, H., Lindsten, T., Wu, J., Lu, C. & Thompson, C. B. Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc. Natl Acad. Sci. USA 108, 11121-11126 (2011).
87. Pfeifer, U. Inhibition by insulin of the formation of autophagic vacuoles in rat liver. A morphometric approach to the kinetics of intracellular degradation by autophagy. J. Cell Biol. 78, 152-167 (1978).
88. Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer, A. J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270, 2320-2326 (1995).
89. Petiot, A., Ogier-Denis, E., Blommaart, E. F., Meijer, A. J. & Codogno, P. Distinct classes of phosphatidylinositol 3-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275, 992-998 (2000).
90. Naito, T., Kuma, A. & Mizushima, N. Differential contribution of insulin and amino acids to the mTORC1-Autophagy pathway in the liver and muscle. J. Biol. Chem. 288, 21074-21081 (2013).
91. Cahill, G. F. Starvation in Man. N. Engl. J. Med. 282, 668-675 (1970).
92. Mortimore, G. E. & Schworer, C. M. Induction of autophagy by amino-Acid deprivation in perfused rat liver. Nature 270, 174-176 (1977).
93. Schworer, C. M., Shiffer, K. A. & Mortimore, G. E. Quantitative relationship between autophagy and proteolysis during graded amino acid deprivation in perfused rat liver. J. Biol. Chem. 256, 7652-7658 (1981).
94. Poso, A. R., Wert, J. J. Jr & Mortimore, G. E. Multifunctional control of amino acids of deprivation-induced proteolysis in liver: role of leucine. J. Biol. Chem. 257, 12114-12120 (1982).
95. Mortimore, G. E., Hutson, N. J. & Surmacz, C. A. Quantitative correlation between proteolysis and macro-And microautophagy in mouse hepatocytes during starvation and refeeding. Proc. Natl Acad. Sci. USA 80, 2179-2183 (1983).
96. Seglen, P. O., Gordon, P. B. & Poli, A. Amino acid inhibition of the autophagic/lysosomal pathway of protein degradation in isolated rat hepatocytes. Biochim. Biophys. Acta 630, 103-118 (1980).
97. Kovacs, A. L., Grinde, B. & Seglen, P. O. Inhibition of autophagic vacuole formation and protein degradation by amino acids in isolated hepatocytes. Exp. Cell Res. 133, 431-436 (1981).
98. Bar-Peled, L. & Sabatini, D. M. Regulation of mTORC1 by amino acids. Trends Cell Biol. 24, 400-406 (2014).
99. Hara, K. et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484-14494 (1998).
100. Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521-534 (2009).
101. Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43-48 (2016).
102. Chantranupong, L. et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165, 153-164 (2016).
103. Han, J. M. et al. Leucyl-TRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149, 410-424 (2012).
104. Duran, R. V. et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol. Cell 47, 349-358 (2012).
105. Sener, A. & Malaisse, W. J. L-Leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature 288, 187-189 (1980).
106. Rebsamen, M. et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 519, 477-481 (2015).
107. Wang, S. et al. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 347, 188-194 (2015).
108. Jung, J., Genau, H. M. & Behrends, C. Amino acid-dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9. Mol. Cell. Biol. 35, 2479-2494 (2015).
109. Deter, R. L. & De Duve, C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J. Cell Biol. 33, 437-449 (1967).
110. Deter, R. L., Baudhuin, P. & De Duve, C. Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J. Cell Biol. 35, C11-C16 (1967).
111. Deter, R. L. Quantitative characterization of dense body, autophagic vacuole, and acid phosphatase-bearing particle populations during the early phases of glucagon-induced autophagy in rat liver. J. Cell Biol. 48, 473-489 (1971).
112. Shelburne, J. D., Arstila, A. U. & Trump, B. F. Studies on cellular autophagocytosis. Cyclic AMP-And dibutyryl cyclic AMP-stimulated autophagy in rat liver. Am. J. Pathol. 72, 521-540 (1973).
113. Adeva-Andany, M. M., Gonzalez-Lucan, M., Donapetry-Garcia, C., Fernandez-Fernandez, C. & Ameneiros-Rodriguez, E. Glycogen metabolism in humans. BBA Clin. 5, 85-100 (2016).
114. Devos, P. & Hers, H. G. Random, presumably hydrolytic, and lysosomal glycogenolysis in the livers of rats treated with phlorizin and of newborn rats. Biochem. J. 192, 177-181 (1980).
115. Schiaffino, S., Mammucari, C. & Sandri, M. The role of autophagy in neonatal tissues: just a response to amino acid starvation? Autophagy 4, 727-730 (2008).
116. Gonzalez, G. A. & Montminy, M. R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680 (1989).
117. Koo, S. H. et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111 (2005).
118. Screaton, R. A. et al. The CREB coactivator TORC2 functions as a calcium-And cAMP-sensitive coincidence detector. Cell 119, 61-74 (2004).
119. Herzig, S. et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183 (2001).
120. Widlund, H. R. & Fisher, D. E. Microphthalamia-Associated transcription factor: A critical regulator of pigment cell development and survival. Oncogene 22, 3035-3041 (2003).
121. Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429-1433 (2011).
122. ORourke, E. J. & Ruvkun, G. MXL-3 and HLH-30 transcriptionally link lipolysis and autophagy to nutrient availability. Nat. Cell Biol. 15, 668-676 (2013).
123. Lapierre, L. R. et al. The TFEB orthologue HLH-30 regulates autophagy and modulates longevity in Caenorhabditis elegans. Nat. Commun. 4, 2267 (2013).
124. Settembre, C. et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 15, 647-658 (2013).
125. Martina, J. A., Chen, Y., Gucek, M. & Puertollano, R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903-914 (2012).
126. Roczniak-Ferguson, A. et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5, ra42 (2012).
127. Settembre, C. et al. A lysosome-To-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095-1108 (2012).
128. Sengupta, S., Peterson, T. R., Laplante, M., Oh, S. & Sabatini, D. M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100-1104 (2010).
129. Liu, Y. et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273 (2008).
130. Zhao, Y. et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12, 665-675 (2010).
131. Liu, H. Y. et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J. Biol. Chem. 284, 31484-31492 (2009).
132. Xiong, X., Tao, R., DePinho, R. A. & Dong, X. C. The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J. Biol. Chem. 287, 39107-39114 (2012).
133. Lee, I. H. et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl Acad. Sci. USA 105, 3374-3379 (2008).
134. Ezaki, J. et al. Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy 7, 727-736 (2011).
135. Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248 (2005).
136. Tsukamoto, S. et al. Autophagy is essential for preimplantation development of mouse embryos. Science 321, 117-120 (2008).
137. Onodera, J. & Ohsumi, Y. Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J. Biol. Chem. 280, 31582-31586 (2005).
138. Suzuki, S. W., Onodera, J. & Ohsumi, Y. Starvation induced cell death in autophagy-defective yeast mutants is caused by mitochondria dysfunction. PLoS ONE 6, e17412 (2011).
139. Reczek, C. R. & Chandel, N. S. ROS-dependent signal transduction. Curr. Opin. Cell Biol. 33, 8-13 (2015).
140. Cardaci, S., Filomeni, G. & Ciriolo, M. R. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J. Cell Sci. 125, 2115-2125 (2012).
141. Filomeni, G., Desideri, E., Cardaci, S., Rotilio, G. & Ciriolo, M. R. Under the ROSthiol network is the principal suspect for autophagy commitment. Autophagy 6, 999-1005 (2010).
142. Scherz-Shouval, R. et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26, 1749-1760 (2007).
143. Hayes, J. D. & McMahon, M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 34, 176-188 (2009).
144. Taguchi, K., Motohashi, H. & Yamamoto, M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140 (2011).
145. Vittorini, S. et al. The age-related accumulation of protein carbonyl in rat liver correlates with the age-related decline in liver proteolytic activities. J. Gerontol. A Biol. Sci. Med. Sci. 54, B318-B323 (1999).
146. Cavallini, G., Donati, A., Gori, Z., Pollera, M. & Bergamini, E. The protection of rat liver autophagic proteolysis from the age-related decline co-varies with the duration of anti-Ageing food restriction. Exp. Gerontol. 36, 497-506 (2001).
147. Donati, A. et al. Age-related changes in the regulation of autophagic proteolysis in rat isolated hepatocytes. J. Gerontol. A Biol. Sci. Med. Sci. 56, B288-B293 (2001).
148. Uddin, M. N., Nishio, N., Ito, S., Suzuki, H. & Isobe, K. Autophagic activity in thymus and liver during aging. Age (Dordr.) 34, 75-85 (2012).
149. Stoller, J. K. & Aboussouan, L. S. A review of aα1-Antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 185, 246-259 (2012).
150. Carlson, J. A. et al. Multiple tissues express alpha 1-Antitrypsin in transgenic mice and man. J. Clin. Invest. 82, 26-36 (1988).
151. Carlson, J. A. et al. Accumulation of PiZ aα1-Antitrypsin causes liver damage in transgenic mice. J. Clin. Invest. 83, 1183-1190 (1989).
152. Qu, D., Teckman, J. H., Omura, S. & Perlmutter, D. H. Degradation of a mutant secretory protein, alpha1-Antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J. Biol Chem. 271, 22791-22795 (1996).
153. Teckman, J. H. et al. The proteasome participates in degradation of mutant alpha 1-Antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol. Chem. 276, 44865-44872 (2001).
154. Teckman, J. H. & Perlmutter, D. H. Retention of mutant aα1-Antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G961-G974 (2000).
155. Kamimoto, T. et al. Intracellular inclusions containing mutant aα1-Antitrypsin Z are propagated in the absence of autophagic activity. J. Biol. Chem. 281, 4467-4476 (2006).
156. Pastore, N. et al. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-Anti-Trypsin deficiency. EMBO Mol. Med. 5, 397-412 (2013).
157. Hidvegi, T. et al. An autophagy-enhancing drug promotes degradation of mutant aα1-Antitrypsin Z and reduces hepatic fibrosis. Science 329, 229-232 (2010).
158. US National Library of Medicine. Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency. ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01379469 (2016).
159. Li, J. et al. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-Antitrypsin deficiency. PLoS ONE 9, e87260 (2014).
160. Mochida, K. et al. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus. Nature 522, 359-362 (2015).
161. Khaminets, A. et al. Regulation of endoplasmic reticulum turnover by selective autophagy. Nature 522, 354-358 (2015).
162. Fumagalli, F. et al. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat. Cell Biol. 18, 1173-1184 (2016).
163. Sveger, T. Liver disease in alpha1-Antitrypsin deficiency detected by screening of 200, 000 infants. N. Engl. J. Med. 294, 1316-1321 (1976).
164. Piitulainen, E., Carlson, J., Ohlsson, K. & Sveger, T. aα1-Antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies. Chest 128, 2076-2081 (2005).
165. Zatloukal, K. et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160, 255-263 (2002).
166. Zatloukal, K. et al. From Mallory to Mallory-Denk bodies: what, how and why? Exp. Cell Res. 313, 2033-2049 (2007).
167. Aishima, S. et al. p62+ hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease. Am. J. Clin. Pathol. 134, 457-465 (2010).
168. Fukuo, Y. et al. Abnormality of autophagic function and cathepsin expression in the liver from patients with non-Alcoholic fatty liver disease. Hepatol. Res. 44, 1026-1036 (2014).
169. Gonzalez-Rodriguez, A. et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 5, e1179 (2014).
170. Liu, B. et al. Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation. Cell Death Dis. 6, e1980 (2015).
171. Wang, S., Pacher, P., De Lisle, R. C., Huang, H. & Ding, W. X. A mechanistic review of cell death in alcohol-induced liver injury. Alcohol. Clin. Exp. Res. 40, 1215-1223 (2016).
172. Ding, W. X. et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 139, 1740-1752 (2010).
173. Eid, N., Ito, Y., Maemura, K. & Otsuki, Y. Elevated autophagic sequestration of mitochondria and lipid droplets in steatotic hepatocytes of chronic ethanol-Treated rats: An immunohistochemical and electron microscopic study. J. Mol. Histol 44, 311-326 (2013).
174. Kharbanda, K. K., McVicker, D. L., Zetterman, R. K. & Donohue, T. M. Jr. Ethanol consumption alters trafficking of lysosomal enzymes and affects the processing of procathepsin L in rat liver. Biochim. Biophys. Acta 1291, 45-52 (1996).
175. Kharbanda, K. K., McVicker, D. L., Zetterman, R. K., MacDonald, R. G. & Donohue, T. M. Jr. Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration. Hepatology 26, 929-934 (1997).
176. Stumptner, C., Omary, M. B., Fickert, P., Denk, H. & Zatloukal, K. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. Am. J. Pathol. 156, 77-90 (2000).
177. Sir, D. et al. The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication. Proc. Natl Acad. Sci. USA 107, 4383-4388 (2010).
178. Li, J. et al. Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J. Virol. 85, 6319-6333 (2011).
179. Tian, Y., Sir, D., Kuo, C. F., Ann, D. K. & Ou, J. H. Autophagy required for hepatitis B virus replication in transgenic mice. J. Virol. 85, 13453-13456 (2011).
180. Luo, M. X. et al. Autophagy mediates HBx-induced nuclear factor-κB activation and release of IL-6, IL-8, and CXCL2 in hepatocytes. J. Cell. Physiol. 230, 2382-2389 (2015).
181. Liu, B. et al. Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy 10, 416-430 (2014).
182. Tanida, I. et al. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy 5, 937-945 (2009).
183. Dreux, M., Gastaminza, P., Wieland, S. F. & Chisari, F. V. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl Acad. Sci. USA 106, 14046-14051 (2009).
184. Guevin, C. et al. Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection. Virology 405, 1-7 (2010).
185. Sir, D. et al. Replication of hepatitis C virus RNA on autophagosomal membranes. J. Biol. Chem. 287, 18036-18043 (2012).
186. Ferraris, P., Blanchard, E. & Roingeard, P. Ultrastructural and biochemical analyses of hepatitis C virus-Associated host cell membranes. J. Gen. Virol. 91, 2230-2237 (2010).
187. Rautou, P. E. et al. Changes in autophagic response in patients with chronic hepatitis C virus infection. Am. J. Pathol. 178, 2708-2715 (2011).
188. Farrell, G. C. & Larter, C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, 99-112 (2006).
189. Brenner, C., Galluzzi, L., Kepp, O. & Kroemer, G. Decoding cell death signals in liver inflammation. J. Hepatol. 59, 583-594 (2013).
190. Yoon, H. & Cha, B. S. Pathogenesis and therapeutic approaches for non-Alcoholic fatty liver disease. World J. Hepatol. 6, 800-811 (2014).
191. Yang, L., Li, P., Fu, S., Calay, E. S. & Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467-478 (2010).
192. Park, H. W. et al. Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers. Nat. Commun. 5, 4834 (2014).
193. Lin, C. W. et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-Alcoholic fatty liver conditions in mice. J. Hepatol. 58, 993-999 (2013).
194. Sinha, R. A. et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 59, 1366-1380 (2014).
195. Sun, L. et al. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway. Am. J. Physiol. Endocrinol. Metab. 309, E925-E935 (2015).
196. Harada, M., Hanada, S., Toivola, D. M., Ghori, N. & Omary, M. B. Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation. Hepatology 47, 2026-2035 (2008).
197. Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008).
198. Hernandez-Gea, V. et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142, 938-946 (2012).
199. White, E. The role for autophagy in cancer. J. Clin. Invest. 125, 42-46 (2015).
200. Rao, S. et al. A dual role for autophagy in a murine model of lung cancer. Nat. Commun. 5, 3056 (2014).
201. Guo, J. Y. et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 27, 1447-1461 (2013).
202. Jiang, P. & Mizushima, N. Autophagy and human diseases. Cell Res. 24, 69-79 (2014).
203. Zhi, X. & Zhong, Q. Autophagy in cancer. F1000Prime Rep. 7, 18 (2015).
204. Rosenfeldt, M. T. et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 504, 296-300 (2013).
205. Inami, Y. et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 193, 275-284 (2011).
206. Takamura, A. et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25, 795-800 (2011).
207. Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809-1820 (2003).
208. Yue, Z., Jin, S., Yang, C., Levine, A. J. & Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA 100, 15077-15082 (2003).
209. Ni, H. M. et al. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. J. Hepatol. 61, 617-625 (2014).
210. Li, L. et al. SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. Cancer Cell 24, 738-750 (2013).
211. Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1aα and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21, 105-120 (2012).
212. Duran, A. et al. The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis. Cancer Cell 13, 343-354 (2008).
213. Gjyshi, O. et al. Kaposis sarcoma-Associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1. J. Virol. 89, 2268-2286 (2015).
214. Russell, R. C., Yuan, H. X. & Guan, K. L. Autophagy regulation by nutrient signaling. Cell Res. 24, 42-57 (2014).
215. Kenerson, H. L., Subramanian, S., McIntyre, R., Kazami, M. & Yeung, R. S. Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. PLoS ONE 10, e0117000 (2015).
216. Kenerson, H. L. et al. Akt and mTORC1 have different roles during liver tumorigenesis in mice. Gastroenterology 144, 1055-1065 (2013).
217. Sporn, M. B. & Liby, K. T. NRF2 and cancer: The good, the bad and the importance of context. Nat. Rev. Cancer 12, 564-571 (2012).
218. Totoki, Y. et al. Trans-Ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 46, 1267-1273 (2014).
219. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 (2012).
220. Adam, J. et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20, 524-537 (2011).
221. Ooi, A. et al. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20, 511-523 (2011).
222. Mitsuishi, Y. et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79 (2012).
223. Saito, T. et al. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming. Nat. Commun. 7, 12030 (2016).
224. Umemura, A. et al. p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells. Cancer Cell 29, 935-948 (2016).